Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > MIV Therapeutics Drug-Eluting Stent Coating

September 24th, 2003

MIV Therapeutics Drug-Eluting Stent Coating

Abstract:
MIV Therapeutics Inc. has received a mid-point milestone interim progress report from the University of British Columbia (UBC) on the development of its proprietary HAp (hydroxyapatite) multi-layer coating with drug-eluting capabilities. "The research work on multi-layer coating applications is progressing on schedule. Our deposition methods have shown promising results with respect to nano-porosity and drug encapsulation for drug-eluting stents."

Source:
MIV Therapeutics

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanostructures Increase Corrosion Resistance in Metallic Body Implants May 24th, 2015

Iranian Scientists Use Magnetic Field to Transfer Anticancer Drug to Tumor Tissue May 24th, 2015

New Antibacterial Wound Dressing in Iran Can Display Replacement Time May 22nd, 2015

Researchers develop new way to manufacture nanofibers May 21st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project